It’s time for the Center for Medicare and Medicaid Services to re-evaluate its coverage of beta amyloid positron emission tomography (PET) scans, US Senators say.
Amyloid PET scans are minimally invasive procedures that can tell normal tissue from amyloid beta tissue, which is a type...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?